medigraphic.com

2014, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (6)

Detection of cytomegalovirus by real-time PCR in HIV-positive plasm

Ruiz-Tachiquín ME, Gómez-Delgado A, Valdez-Salazar HA, Aguilera P

Language: Spanish
References: 30
Page: 624-629
PDF size: 128.42 Kb.


ABSTRACT

Background: Cytomegalovirus is a betaherpesvirus responsible for persistent infections that are generally asymptomatic in healthy individuals. In the absence of an effective immune response, as in neonates, cancer patients, organ transplant recipients, individuals with AIDS, etc., cytomegalovirus may cause severe disease. Early detection of this virus would prevent serious health consequences in immunocompromised patients; it is important to employ sensitive methods and accurate detection to support treatment-related decision making. Real-time molecular methods, such as the polymerase chain reaction, possess higher sensitivity to detect positive samples.
Methods: We compared the sensitivity and specificity of the following detection methods: the endpoint PCR trade-validated method (Pol, viral gene target) and real-time PCR, which detects viral genes Pol (early gene), and pp65 (late gene). We performed a cross-sectional study of 43 human immunodefi ciency virus-positive samples.
Results: The molecular detection methods in real-time detected a greater number of cytomegalovirus-positive samples than those at the endpoint.
Conclusions: There must be at least two independent cytomegalovirus target-genes in order to make the detection by real-time PCR.


REFERENCES

  1. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol. 1990; 154:125-69.

  2. Emery V. Investigation of CMV disease in immunocompromised patients. J Clin Pathol. 2001;54(2): 84-8.

  3. Mecarski ES, Courcelle CT. Cytomegalovirus and their replication. En: Knipe DMP, Howley M, Griffi n DE, Lamb RA, Martin MA, Roizman B, Straus SE editores. Fields Virology. Philadelphia, Pa: Lippincott- Raven; 2001. p. 2629-73.

  4. luliano R, Forastieri G, Brizzi M, Mecocci L, Mezzotta F, Ceccherin-Nell L. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline. J Acquir Immune Defi c Syndr Hum Retrovirol. 1997;14(5):408-14.

  5. Deayton JR. Changing trends in cytomegalovirus disease in HIV-infected patients. Herpes. 2001;8(2): 37-40.

  6. Centers for Disease Control and Prevention. 1993 Revised classifi cation system for HIV infection and expanded surveillance case defi nition for AIDS among adolescents and adults. Morbid Mortal Weekly Rep. 1993;41(RR-17):1-19. Texto libre en http:// www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm

  7. Sainz B Jr, LaMarca HL, Garry RF, Morris CA. Synergistic inhibition of human cytomegalovirus replication by interferon-alfa/beta and interferon-gamma. BMC Virol J. 2005;2:14. Texto libre en http://www. virologyj.com/content/2/1/14

  8. García-Ramírez J, Ruchti J, Huang H, Simmen K, Angulo A, Ghazal P. Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression. J Virol. 2001;75 (1):26-35.

  9. Grzimek N, Dreis D, Schmalz S, Reddehase M. Random, asynchronous, and asymmetric transcriptional activity of enhancer-fl anking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol. 2001;75(6):2692-705. Texto libre en http://jvi.asm.org/content/75/6/2692.long

  10. Wattamano P, Clayton J, Kopicko J, Kissinger P, Elliot S, Jarrott C, et al. Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis. J Clin Microbiol. 2000;38(2):727- 32. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC86188/

  11. Pang XL, Chui L, Featon J, LeBlanc B, Preiksaitis JK. Comparison of lightcycler-based PCR, COBAS Amplicor CMV monitor, and pp65 antigenemia assay for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol. 2003;41(7):3167-74.

  12. Pellegrin I, Garrigue I, Binquet C, Chene G, Neau D, Bonot P, et al. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodefi ciency virus-positive patients. J Clin Microbiol. 1999;37(10):3124-32.

  13. Amorim ML, Cabeda JM, Seca R, Mendes AC, Castro AP, Amorim JM. CMV infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays. BMC Infect Dis. 2001;1:2. Texto libre en http://www.biomedcentral. com/1471-2334/1/2

  14. Preiser W, Rabenau H, Vogel Ju, Brixner V, Doerr HW. Performance characteristics of an automated PCR assay for the quantifi cation of cytomegalovirus DNA in plasma. J Virol Microbiol. 2002;101(1-2):149-57.

  15. Najioullah F, Thouvenot D, Lina B. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J Virol Methods. 2001;92(1):55-64.

  16. Onishi Y, Mori S, Higuchi A, Kim SW, Fukuda T, Heike Y, et al. Early detection of plasma cytomegalovirus DNA by real-time PCR after allogeneic hematopoietic stem cell transplantation. Tohoku J Exp Med. 2006;210(2):125-35. Texto libre en https://www.jstage. jst.go.jp/article/tjem/210/2/210_2_125/ _article

  17. Yerly S, Perrin L, Van-Delden C, Schaffer S, Thamm S, Wunderli W, Kaiser L. Cytomegalovirus quantifi cation in plasma by an automated real-time PCR assay. J Clin Virol. 2007;38(4):298-303.

  18. Gault E, Michel Y, Dehée A, Belabani C, Nicolas J, Garbarg-Chenon A. Quantifi cation of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol. 2001;39(2):772-5. Texto libre en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC87818/

  19. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis JH. Quantifi cation of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol. 2001;39(12):4362- 9. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC88550/

  20. Kalpoe JS, Kroes AC, de Jong MD, Schinkel J, de Brouwer CS, Beersma MF, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and defi nition of treatment criteria by Rev Med Inst Mex Seguro Soc. 2014;52(6):624-9 629 Ruiz-Tachiquín ME et al. Citomegalovirus en plasmas positivos a VIH analysis of correlation to antigen detecction. J Clin Microbiol. 2004;42(4):1498-504. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC387533/

  21. Caliendo A, Ingersoll J, Fox-Canele A, Pargman S, Bythwood T, Hayden M, et al. Evaluation of real-time PCR laboratory-developed test using analyte-specific reagents for cytomegalovirus quantifi cation. J Clin Microbiol. 2007;45(6):1723-7. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC1933050/

  22. Nolan T, Hands RE, Bustin SA. Quantifi cation of mRNA using real-time RT-PCR. Nat Protoc. 2006;1(3): 1559-82.

  23. Machida U. Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, et al. Real-Time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol. 2000;38(7):2536-42.

  24. Gerna G, Baldanti F, Lilleri D, Parea M, Alessandrino E, Pagani A, et al. Human cytomegalovirus immediate- early mRNA detection by nucleic acid sequencebased amplifi cation as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol. 2000;38(5):1845-53. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC86605/

  25. Roche Molecular Systems, Inc. COBAS AMPLICOR MONITORTM Test, Roche Diagnostics. P/N: 03563898190. Rev. 2003;1:1-38.

  26. Cohen JA Coeffi cient of agreement for nominal scales. Educational Psychological Measurement. 1960;20(1):37-46.

  27. Fleiss JL, Cohen J, Everitt BS. Large-sample standard errors of kappa and weighted kappa. Psychol Bul. 1969;72(5):323-7.

  28. Fleiss JL. Statistical methods for rates and ´proportions. Second edition. New York: John Wiley & Sons; 1981.

  29. Duffau TG, Navarrete RL, Fernández CC. Estudio de concordancia clínica en educandos de pre y postítulo en pediatría. Rev Chil Pediatr. 2000;71(4): 340-6.

  30. González-Calixto C, Ruiz-Tachiquín ME, Burgueño- Ferreira J, Aguilera P, Espinoza-Rojo M. Detección temprana y altamente sensible de citomegalovirus en muestras de plasma humano VIH-positivas. Bioquimia. 2009;34(3):129-36.




2020     |     www.medigraphic.com